Prognostic factors in the treatment of HIV-associated non-Hodgkin lymphoma (HANHL): Analysis of ACTG 142 (low-dose vs. standard-dose mBACOD + GM-CSF) Meeting Abstract


Authors: Straus, D. J.; Huang, J.; Testa, M. A.; Levine, A. M.; Kaplan, L. D.
Abstract Title: Prognostic factors in the treatment of HIV-associated non-Hodgkin lymphoma (HANHL): Analysis of ACTG 142 (low-dose vs. standard-dose mBACOD + GM-CSF)
Meeting Title: 1st National AIDS Malignancy Conference
Journal Title: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Volume: 14
Issue: 4
Meeting Dates: 1997 Apr 28-30
Meeting Location: Bethesda, MD
ISSN: 1077-9450
Publisher: Lippincott Williams & Wilkins  
Date Published: 1997-04-01
Start Page: A38
Language: English
ACCESSION: WOS:A1997WU25100120
PROVIDER: wos
PUBMED: 9138751
Notes: Meeting Abstract: 89 -- Source: Wos
Citation Impact
MSK Authors
  1. David J Straus
    356 Straus